limula-biotech.com
About company
Limula Biotech proposes an automated gene therapy manufacturing platform that operates at the patient bedside. This platform allows to automatically manufacture, from a patient white blood cell sample, genetically engineered cells at its bedside. Limula Biotech is building the first fully contained automated system for CGT manufacturing, allowing rapid and safe production of treatments directly at the patients beside. By enabling distributed manufacturing at the hospital, Limula’s technology will save time, cut costs, simplify logistics, and ultimately increase the safety and accessibility of these cutting edge personalized treatments. Founded in 2018, Limula Biotech envision to bring ex vivo gene-engineered cell therapies to the people.
